0001193125-21-092284.txt : 20210324 0001193125-21-092284.hdr.sgml : 20210324 20210324124851 ACCESSION NUMBER: 0001193125-21-092284 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210324 FILED AS OF DATE: 20210324 DATE AS OF CHANGE: 20210324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MorphoSys AG CENTRAL INDEX KEY: 0001340243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38455 FILM NUMBER: 21767530 BUSINESS ADDRESS: STREET 1: SEMMELWEISSTR. 7 CITY: PLANEGG STATE: 2M ZIP: 82152 BUSINESS PHONE: 49 89 89927-0 MAIL ADDRESS: STREET 1: SEMMELWEISSTR. 7 CITY: PLANEGG STATE: 2M ZIP: 82152 FORMER COMPANY: FORMER CONFORMED NAME: MORPHOSYS AG DATE OF NAME CHANGE: 20050929 6-K 1 d161375d6k.htm FORM 6-K Form 6-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF A FOREIGN ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For March 24, 2021

Commission File Number 1-38455

 

 

MorphoSys AG

 

 

Semmelweisstrasse 7

82152 Planegg

Germany

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒                Form 40-F  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ☐                No  ☒

If ‘‘Yes’’ is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    MORPHOSYS AG (Registrant)
Date: March 24, 2021     By:  

/s/ i.A. Dr. Julia Neugebauer

      Name:   Dr. Julia Neugebauer
      Title:     Senior Director Investor Relations
    By:  

/s/ i.A. Isabelle Degbegni

      Name:  Isabelle Degbegni
      Title:    Director Investor Relations
 EX-99.1 2 d161375dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Notification of managers` transactions according to article 19 MAR

Via Fax to BaFin (+49(0)228/4108-62963) and to the issuer

 

1   Details of the person discharging managerial responsibilities/person closely associated
a)   Name    Sung Lee
2   Reason for the notification
a)   Position/status    Member of the managing body of MorphoSys AG
b)   Initial notification/Amendment    Initial notification
3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)   Name    MorphoSys AG
b)   LEI    529900493806K77LRE72
4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)  

Description of the financial instrument. type of instrument

Identification code

   

American Depositary Shares (ADS), CUSIP: 617760202; ratio: 4 ADS = 1 ordinary share of MorphoSys AG (ISIN: DE0006632003)

For trade on Nasdaq

b)   Nature of the transaction    Acquisition
c)   Price(s) and volume(s)    Price(s)      Volume(s)  
     22.75 US-$    22,750.00 US-$            
d)  

Aggregated information

 

-   Aggregated volume

 

-   Price

   

 

22,750.00 US-$

 

22.75 US-$

e)   Date of the transaction    2021-03-23; UTC+1
f)   Place of the transaction    Nasdaq

 

(1)

Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council as regards an exemption for certain third countries public bodies and central banks. the indicators of market manipulation. the disclosure thresholds. the competent authority for notifications of delays. the permission for trading during closed periods and types of notifiable managers’ transactions (see page 1 of this Official Journal).